Bruin Biometrics Formalizes Management Structure with Appointment of Jeff
Greiner and Eve Kurtin to Board of Directors, Plus Additional Executive
LOS ANGELES, Dec. 2, 2013
LOS ANGELES, Dec. 2, 2013 /PRNewswire/ --Bruin Biometrics, LLC ("BBI") a
medical device company developing innovative, point of care diagnostic
devices, announced today the appointment of two new board members and the
expansion of the executive team.
(Logo; http://photos.prnewswire.com/prnh/20131018/LA00429LOGO )
Jeff Greiner joins the BBI board after serving 18 years leading Advanced
Bionics, a medical device company that developed spinal cord stimulators and
cochlear implants. The company was soldfor over $3 billion dollars and is now
owned by Boston Scientific (neuromodulation division) and Sonova (cochlear
Eve Kurtin joins the BBI Board with over 20 years of experience as an
operating executive and investor in healthcare. Eve is Managing Director of
Pacific Venture Group and Senior Advisor of VantagePoint Capital Partners. She
is also a founding member of the RAND Health Board of Advisors, an assembly of
national leaders working to improve the U.S. healthcare system.
Rob Pecsar joins BBI as Vice President of Research & Development. Rob has
previously launched 18 medical products at a variety of companies including
Alaris Medical Systems, Cardinal Health, CareFusion, Gen-Probe, IMED, and
Armin Beck joins BBI as Vice President of Quality, Regulatory, Manufacturing,
and Operations. He has over 30 years experience leading international
commercial product launches and most recently directed Quality Assurance,
Regulatory, and Clinical Affairs at Cardica, Inc.
Mark Bruns joins BBI as Vice President of Commercial Operations and Sales.
Mark has over 30 years of experience, most recently as a transformational
leader in sales and marketing at Alaris Medical Systems, Cardinal Health, and
Sally Grigoriev joins BBI as Senior Advisor, Operations.Sally was previously
Senior Vice President of Manufacturing and Operations at CareFusion and
Cardinal Health. She has over 25 years of R&D, Quality, Regulatory,
Manufacturing, and Operations experience within the medical device industry.
BBI Chief Executive Martin Burns commented, "We have been extremely diligent
about finding the right people who understand BBI's strategy and also have the
talent to execute upon BBI's business goals. Our combined team has launched
over 30 medical products and technologies, and we are united in our mission to
solve pressing clinical challenges."
To learn more about BBI please visit www.bruinbiometrics.com .
Contact: Nicole Bolton, email@example.com
Press spacebar to pause and continue. Press esc to stop.